Bayer AG | Balance Sheet

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,829
2,057
2,131
5,424
9,098
5,002
Total Accounts Receivable
9,812
11,387
12,549
16,103
12,055
13,727
Inventories
7,129
8,478
8,550
8,408
6,550
10,961
Other Current Assets
1,310
1,257
1,474
1,664
3,535
2,507
Total Current Assets
20,080
23,179
24,704
31,599
31,238
32,197
Net Property, Plant & Equipment
10,015
11,428
12,375
13,114
7,633
12,944
Total Investments and Advances
621
1,279
1,287
1,804
5,413
2,717
Long-Term Note Receivable
1,153
381
373
553
570
996
Intangible Assets
18,776
31,000
31,274
29,879
26,425
74,892
Other Assets
386
422
502
593
347
534
Total Assets
55,173
74,871
77,913
85,410
76,820
131,439
ST Debt & Current Portion LT Debt
3,324
3,080
2,823
3,014
1,269
Accounts Payable
4,473
5,363
5,945
6,410
5,129
Income Tax Payable
458
859
995
1,724
1,094
Other Current Liabilities
6,125
6,615
7,289
8,229
6,773
Total Current Liabilities
14,380
15,917
17,052
19,377
14,265
Long-Term Debt
5,396
18,136
16,346
15,902
12,464
Provision for Risks & Charges
9,345
13,829
12,613
12,914
9,386
Deferred Taxes
550
2,270
2,648
4,206
2,980
Other Liabilities
556
1,859
1,707
1,658
1,630
Total Liabilities
34,369
54,653
52,468
53,513
39,959
Common Equity (Total)
20,718
20,106
24,265
30,333
36,801
Total Shareholders' Equity
20,718
20,106
24,265
30,333
36,801
Total Equity
20,804
20,218
25,445
31,897
36,861
Liabilities & Shareholders' Equity
55,173
74,871
77,913
85,410
76,820
Accumulated Minority Interest
86
112
1,180
1,564
60

About Bayer

View Profile
Address
Kaiser-Wilhelm-Allee 1
Leverkusen Nordrhein-Westfalen 51368
Germany
Employees -
Website http://www.bayer.com
Updated 07/08/2019
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents.